First phase III study of BUPI for pain management in oral mucositis in cancer patients

Trial Profile

First phase III study of BUPI for pain management in oral mucositis in cancer patients

Planning
Phase of Trial: Phase III

Latest Information Update: 10 May 2016

At a glance

  • Drugs Bupivacaine (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 10 May 2016 According to Moberg media release, company will start enrollment of patients for this study in the first half of 2017.
    • 28 Mar 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top